Ono Pharmaceutical Co., Ltd.

Overview

Ono Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company primarily involved in research, development, manufacture, and sales of pharmaceuticals. The company's innovative medicines target a wide array of diseases and conditions, including those in oncology and autoimmune disorders.

Core services & business areas

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Ono Pharmaceutical Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Ono Pharmaceutical Co., Ltd. holds 0 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PROSTAGLANDIN E1Inactive2008-07-30
• SIVELESTAT SODIUM HYDRATEInactive2001-02-13
• ONO-2506 DRUG SUBSTANCEInactive1999-06-30
• PROSTAGLANDIN E1Inactive1995-05-31
• MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN FUKUI, JAPAN.Inactive1994-12-30
• ALPROSTADIL ALFADEX I.V.Inactive1993-08-10
• FACILITY AND OPERATING PROCEDURES IN OSAKA, JAPANInactive1993-06-29

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Ono Pharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.